Borrayo-Sánchez G, Puente-Barragán A, Almonte C, Meaney E, Borrayo-Sánchez G, Mendonça-Rivera MA, Almonte C, Dueñas-Criado KA, Zilberman J, Artucio C, Madrid-Miller A, Puente-Barragán AC

Idioma: Inglés [English version]
Referencias bibliográficas: 5
Paginas: s421-422
Archivo PDF: 102.59 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. Seattle, WA, USA: Institute for Health Metrics and Evaluation, 2020. [Accessed April 23, 2021] Available in: http://ghdx.healthdata.org/gbd-results-tool

2. Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022; 145 (8): e153-e639.

3. Del-Sueldo MA, Mendonca-Rivera MA, Sánchez-Zambrano MB, Zilberman J, Múnera-Echeverri AG, Paniagua M, et al. Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer. Arch Cardiol Mex. 2022; 92 (Supl): 1-68.

4. Vogel B, Acevedo M, Appelman Y, Bairey MCN, Chieffo A, Figtree GA et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397: 2385-2438.

5. Wenger NK, Lloyd-Jones DM, Elkind MSV, Fonarow GC, Warner JJ, Alger HM et al. Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: A Presidential Advisory from the American Heart Association. Circulation. 2022; 145: e1059-e1071.